Vincent S LoPriore insider trades: Hepion Pharmaceuticals (HEPA) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Vincent reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 3, 2026 | HEPA | ↑ Buy | 8,000,000 | $0.05 | $400K | By Gravitas Capital LP | Aug 12, 2026 (9d) |
| Aug 3, 2026 | HEPA | ↑ Buy | 2,000,000 | $0.05 | $100K | By Invictus Capital Advisors Pension Pla | Aug 12, 2026 (9d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other HEPA insiders
Open-market trades in the last 12 months
About Vincent S LoPriore's insider trades
Vincent S LoPriore is Executive Chairman at Hepion Pharmaceuticals (HEPA). Since Aug 3, 2026, Vincent has reported 2 open-market purchases worth $500K and no sales on SEC Form 4. In the last 12 months: 2 buys ($500K).
Their filings also include grants and awards (3 filings), other transactions (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every HEPA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.